Publications by authors named "M Strueber"
Article Synopsis
- Extended criteria donor (ECD) hearts from donation after brain death (DBD) are often underused for transplants due to cold storage issues; this study explored the impact of an extracorporeal perfusion system on their utilization and outcomes.
- In a multicenter study with adult recipients, 173 ECD DBD hearts were perfused, achieving an 87% transplantation success rate, with 30-day survival at 97% and only 6.7% experiencing severe primary graft dysfunction (PGD).
- The outcomes demonstrated that using this perfusion system not only reduced severe PGD but also supported good patient survival rates through two years, suggesting a way to significantly increase heart transplant availability for patients in need.
Background: The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation of the HeartWare HVAD System, leading to Food and Drug Administration approval. We sought to analyze 24-month adverse event (AE) rates, including a temporal analysis of the risk profile, associated with the thoracotomy approach for the HVAD system.
Methods: AEs from the LATERAL trial were evaluated over 2 years postimplant.
Background: The increasing prevalence of heart failure has led to the expanded use of left ventricle assist devices (VADs) for end-stage heart failure patients worldwide. Technological improvements witnessed the development of miniaturized VADs and their implantation through less traumatic non-full sternotomy approaches using a lateral thoracotomy (LT). Although adoption of the LT approach is steadily growing, a lack of consensus remains regarding patient selection, details of the surgical technique, and perioperative management.
View Article and Find Full Text PDF